- Bayer Group
- About Bayer
- Mission & Values
- Strategic Alignment
- Outlook and Targets
- Opportunity and Risk Report
- Corporate Governance
- Articles of Incorporation
- Board of Management
- Supervisory Board
- Sustainability and Commitment
- Listing and Key Figures
- Share Price
- Stockholders' Portal
- Ownership Structure
- Stock Programs
- Stock History
- Annual Stockholders’ Meeting 2017
- Live Events
- Investor Conferences
- Stockholders' Meeting
- Press Conferences
- Other Presentations
- Inside Information
- Investor News
- Investor News 2016
- Investor News 2015
- Investor News 2014
- Investor News 2013
- Investor News 2012
- Investor News 2011
- Investor News 2010
- Investor News 2009
- Investor News 2008
- Investor News 2007
- Investor News 2006
- Investor News 2005
- Investor News 2004
- Investor News 2003
- Investor News 2002
- Investor News 2001
- Investor News 2000
Answers to our investors' frequently asked questions:
On August 1, 1863 businessman Friedrich Bayer and master dyer Johann Friedrich Weskott established a dyestuffs factory in Barmen, now a part of Wuppertal. Soon afterwards, in 1865, the two men purchased an interest in a coal tar dye factory in the United States and began exporting intermediates. In 1876 a dyestuffs factory was opened in Moscow. The descendants of Bayer and Weskott established the joint stock company Farbenfabriken vorm. Friedr. Bayer & Co. on July 1, 1881. The Flers plant in northern France started production in 1883. In 1884 the chemist Carl Duisberg began his career at Bayer. Under his management, Bayer scientists made pioneering discoveries. The Pharmaceutical Department was established in 1888. In 1891 the Leverkusen site was purchased. Bayer researcher Dr. Felix Hoffmann first synthesized acetylsalicylic acid in a chemically pure and stable form in 1897. Aspirin® was registered as a trademark in 1899 and became the world's favorite pain killer. In 1912 the company's headquarters were transferred to Leverkusen. Farbenfabriken vorm. Friedr. Bayer & Co. merged with other companies to form I.G. Farbenindustrie AG in 1925. Leverkusen became the main production center of the I.G.'s Lower Rhine operating consortium. Following the Second World War, the Allies seized and later broke up I.G. Farben. Bayer was re-established as Farbenfabriken Bayer AG in 1951 and changed its name to Bayer AG in 1972. The push for expansion as an international health care and chemicals group began.
In 2013 the Bayer Group is celebrating its 150th anniversary.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
As of December 31, 2016 the number of employees in the Bayer Group was 115,200.
|Europe / Middle East / Africa||59,500|
|- there of Germany||37,000|
|Asia / Pacific||27,400|
For fiscal 2016 the Bayer Group reported net sales of € 46,769 million and EBITDA before special items of € 11,302 million.
2016 Key Data by Segment
The consolidated financial statements of the Bayer Group as of December 31, 2016, were prepared by Bayer Aktiengesellschaft (Bayer AG) according to the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB), London, United Kingdom, and the interpretations of the IFRS Interpretations Committee (IFRS IC), both as endorsed by the European Union and in effect at the end of the reporting period. The applicable further requirements of Section 315a of the German Commercial Code were also taken into account.
The fiscal year is the calendar year.
Bayer welcomes the Corporate Governance Code. We have a long-standing committment to these principles in the interest of value creation.
All publications can be ordered or subscribed from our website Publications. After selecting the documents you need, you will be prompted to enter all information required for ordering.
The Bayer stock was listed for the first time on October 2, 1953 on the Frankfurt Stock Exchange.
How to invest in Bayer shares?
The capital stock of Bayer AG is traded as no-par registered shares on electonic trading platformas like Xetra® as well as at several stock exchanges. You can buy Bayer ordinary shares through any supplier of brokerage services, usually banks. To do so, you need a custody account in which your shares are administered. It is not possible to acquire the shares directly through Bayer.
How to buy Bayer ADRs?
In the United States, Bayer stock has been traded under a OTC Level l ADR Program since September 27, 2007. The ticker symbol is BAYRY. Trading information is obtainable from the Pinksheets OTC website.
Bayer ADRs are issued by The Bank of New York Mellon, acting as depositary.
Under the German Securities Trading Act (Wertpapierhandelsgesetz), holders of voting securities of a listed German company must notify that company of the level of their holding whenever it reaches, exceeds or falls below specified thresholds. These thresholds are 3, 5, 10, 15, 20, 25, 30, 50 and 75 percent of the company’s outstanding voting securities.
To motivate and enhance their performance, Bayer allows its employees to benefit directly from the company's success. We offer three different programs for defined participant groups. Eligibility for the different programs varies with an employee’s position in the company, since people at higher levels of management are considered to have a greater direct influence on the company’s economic performance and thus on the performance of Bayer stock. Bayer therefore offers the stock program Aspire for members of the Board of Management, for other Group Executives (members of the “Group Leadership Circles”), and for other senior managers, and a Stock Participation Program for all other groups of employees.
Information about the dividend for fiscal 2016
Conforming to the proposal of the Board of Management and the Supervisory Board, the Annual Stockholders’ Meeting on April 28, 2017 passed the resolution to pay a dividend for fiscal 2016 of EUR 2.70 per share. The resulting payout ratio of 37 percent calculated on core earnings per share (see Annual Report 2016, Chapter 2.2.1 of the Combined Management Report) is within our target corridor of 30 percent to 40 percent.
The dividend yield calculated on the share price of €99.13 at year end 2016 amounts to 2.7 percent and the total dividend payment to €2,233 million.
The next Annual Stockholders’ Meeting will be held on Friday, May 25, 2018.
The former MaterialScience subgroup became a separate economic and legal entity on September 1, 2015, and operates under the name Covestro. Covestro AG was floated on the stock market on October 6, 2015.
On June 7, 2017, Bayer reduced its direct interest in Covestro from 53.3% to 44.8%, by placing 17.25 million shares at a price of €62.25 per share. Bayer AG’s interest in Covestro was reduced by a further 4 percentage points through the contribution of Covestro shares to the Bayer Pension Trust e. V. In addition, Bayer has issued €1 billion in bonds maturing in 2020 that can be redeemed in cash, Covestro shares or a combination of the two. Covestro continues to be fully consolidated in Bayer’s financial statements, as, even with these transactions having been completed, Bayer will still hold the de facto majority at a Covestro stockholders’ meeting.